Hepatology · Article 74

How Should Chronic Constipation Be Investigated?

Chronic constipation evaluation requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Chronic constipation evaluation clinical reference — Related free clinical resource: Guideline-Based Management in Hepatology.

Chronic constipation evaluation: practical clinical approach

This page focuses on Chronic constipation evaluation with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Chronic constipation evaluation

Clinical takeaway: For Chronic constipation evaluation, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer in brief: Most chronic constipation can be evaluated with a careful history, medication review, digital rectal examination and limited laboratory testing rather than routine colonoscopy or extensive imaging. The key first distinction is between secondary causes, chronic idiopathic constipation, IBS with constipation, and defecatory disorders. Patients who fail appropriate laxative therapy or have symptoms of outlet dysfunction should undergo anorectal testing before escalating indefinitely to additional medications.

Key clinical points

Clarify stool frequency, consistency, straining, incomplete evacuation and manual maneuvers.
Review opioids, anticholinergics, calcium-channel blockers, iron and other constipating drugs.
Digital rectal examination can identify dyssynergic defecation clues.
Anorectal manometry and balloon expulsion testing are appropriate when a defecatory disorder is suspected.

Define the phenotype

Constipation is more than infrequent stool. Patients may have hard stools, excessive straining, incomplete evacuation, prolonged toileting or the need for digital maneuvers. Abdominal pain related to defecation suggests IBS-C rather than isolated chronic idiopathic constipation.

Look for secondary causes

Medication effects are common. Neurologic disease, hypothyroidism, hypercalcemia, diabetes, pregnancy and structural lesions should be considered when suggested by the history. Routine broad laboratory panels are usually low yield; targeted testing is preferable.

Examination

A thoughtful digital rectal examination can assess resting tone, squeeze, perineal descent and whether the patient can relax the anal sphincter while simulating defecation. Failure to relax or paradoxical contraction should prompt formal anorectal testing.

Treatment as part of evaluation

Initial therapy often includes appropriate fiber in selected patients and an osmotic laxative. The 2023 AGA-ACG guideline strongly recommends polyethylene glycol for chronic use and supports linaclotide, plecanatide and prucalopride after unsuccessful OTC therapy. Persistent symptoms despite effective stool softening should raise concern for pelvic-floor dysfunction rather than simply “stronger constipation.”

Practical approach

1. Define constipation phenotype and check medication/secondary causes.

2. Perform focused abdominal and digital rectal examination.

3. Use colonoscopy only for screening, alarm features or a structural indication.

4. If outlet symptoms or refractory disease persist, perform anorectal testing before escalating therapy indefinitely.

Common errors to avoid

Ordering colonoscopy simply because constipation is chronic.
Missing pelvic-floor dysfunction by never performing a rectal examination or anorectal testing.

Trainee takeaway

Most chronic constipation can be evaluated with a careful history, medication review, digital rectal examination and limited laboratory testing rather than routine colonoscopy or extensive imaging. The examination question is usually less about memorizing one cutoff than recognizing which finding changes the next clinical decision.

Frequently asked questions

Does every patient with constipation need a colonoscopy?

No. Colonoscopy is guided by age-appropriate screening, alarm features and other indications, not constipation alone.

When should pelvic-floor testing be considered?

When patients describe outlet symptoms or fail reasonable laxative therapy, especially when digital rectal examination suggests dyssynergia.

References

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014. ISBN 978-1500855321.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children, 7th ed., Vols I–II. CAPstone Academic Publishers; 2013.

3. Chang L, Chey WD, Imdad A, et al. AGA-ACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Am J Gastroenterol. 2023;118:936-954.

Editorial note: This educational article synthesizes Dr. Thomson’s teaching framework with current society guidance. Recommendations should be checked against the latest guideline, local formulary, regulatory labeling and the individual clinical context before patient-specific use.

← Back to Clinical Questions